10
Oct

Gilead Sciences picked up a much-anticipated FDA approval for Harvoni, a combination therapy for hepatitis C that promises to cure the majority of patients without the need for painful injections that have plagued patients for years.

…read more

Source: Gilead wins FDA approval for its hep C combo pill, a blockbuster in the making

    

0 No comments